Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome After Transcatheter and Surgical Aortic Valve Replacement
Marco Barbanti(University of Padua), Martin B. Leon(Columbia University Irving Medical Center), Vasilis Babaliaros(Valve (United States)), Susheel Kodali(Columbia University Irving Medical Center), D. Craig Miller(Harvard University), Christopher Thompson(Toronto General Hospital), John G. Webb(St. Paul's Hospital), Raj Makkar(Cedars-Sinai Medical Center), Rebecca T. Hahn(Columbia University Irving Medical Center), Pamela S. Douglas(Duke University), Robert Boone, Alan Zajarías(Washington University in St. Louis), Irene Hueter(NewYork–Presbyterian Hospital), Tom McAndrew, Craig R. Smith(University of Arizona), Ted Feldman(Edwards Lifesciences (United States)), Wilson Y. Szeto(Mount Sinai Hospital), Philip Green(Columbia University Irving Medical Center)
Cited by 170
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
MAPMAKER: An interactive computer package for constructing primary genetic linkage maps of experimental and natural populations
|Genomics|1987|6.7k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k